title: Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial.
authors.forename: E
authors.initials: E
authors.lastname: Willems
authors.forename: F
authors.initials: F
authors.lastname: Baron
authors.forename: E
authors.initials: E
authors.lastname: Baudoux
authors.forename: N
authors.initials: N
authors.lastname: Wanten
authors.forename: L
authors.initials: L
authors.lastname: Seidel
authors.forename: J-F
authors.initials: JF
authors.lastname: Vanbellinghen
authors.forename: C
authors.initials: C
authors.lastname: Herens
authors.forename: A
authors.initials: A
authors.lastname: Gothot
authors.forename: P
authors.initials: P
authors.lastname: Frère
authors.forename: C
authors.initials: C
authors.lastname: Bonnet
authors.forename: K
authors.initials: K
authors.lastname: Hafraoui
authors.forename: G
authors.initials: G
authors.lastname: Vanstraelen
authors.forename: G
authors.initials: G
authors.lastname: Fillet
authors.forename: Y
authors.initials: Y
authors.lastname: Beguin
mesh_terms: D000328:Adult; D000368:Aged; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D002292:Carcinoma, Renal Cell / Q000556:secondary / Q000601:surgery; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D019337:Hematologic Neoplasms / Q000601:surgery*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D053208:Kaplan-Meier Estimate; D007680:Kidney Neoplasms / Q000473:pathology; D008212:Lymphocyte Depletion; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000601:surgery; D009196:Myeloproliferative Disorders / Q000601:surgery; D036102:Peripheral Blood Stem Cell Transplantation / Q000379:methods* / Q000706:statistics & numerical data; D019172:Transplantation Conditioning / Q000379:methods*; D014184:Transplantation, Homologous; D014740:Vidarabine / Q000031:analogs & derivatives / Q000627:therapeutic use; D014916:Whole-Body Irradiation
chemical_list: D007166:Immunosuppressive Agents; D014740:Vidarabine; C024352:fludarabine